Roche Holding AG
RHHBYFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
70,506
Cost of Revenue
18,400
Gross Profit
52,107
Gross Margin
73.9%
Operating Income
15,161
Operating Margin
21.5%
Net Income
9,353
Net Margin
13.3%
EPS (Basic)
$1.30
EPS (Diluted)
$1.29
EBITDA
18,779
EBITDA Margin
26.6%
2023
12/31/2023
Revenue
68,298
Cost of Revenue
17,625
Gross Profit
50,674
Gross Margin
74.2%
Operating Income
17,396
Operating Margin
25.5%
Net Income
12,993
Net Margin
19.0%
EPS (Basic)
$1.80
EPS (Diluted)
$1.79
EBITDA
20,807
EBITDA Margin
30.5%
2022
12/31/2022
Revenue
74,370
Cost of Revenue
21,286
Gross Profit
50,222
Gross Margin
67.5%
Operating Income
19,748
Operating Margin
26.6%
Net Income
14,036
Net Margin
18.9%
EPS (Basic)
$1.94
EPS (Diluted)
$1.92
EBITDA
23,504
EBITDA Margin
31.6%
2021
12/31/2021
Revenue
70,965
Cost of Revenue
22,264
Gross Profit
48,701
Gross Margin
68.6%
Operating Income
19,530
Operating Margin
27.5%
Net Income
15,741
Net Margin
22.2%
EPS (Basic)
$2.05
EPS (Diluted)
$2.03
EBITDA
25,072
EBITDA Margin
35.3%
2020
12/31/2020
Revenue
65,905
Cost of Revenue
18,480
Gross Profit
47,425
Gross Margin
72.0%
Operating Income
20,954
Operating Margin
31.8%
Net Income
16,153
Net Margin
24.5%
EPS (Basic)
$2.09
EPS (Diluted)
$2.07
EBITDA
25,955
EBITDA Margin
39.4%